Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: a complex new scenario

被引：2
|
作者：
Giacobbe, Daniele Roberto [1 ,2 ]
Ball, Lorenzo [3 ,4 ]
Magnasco, Laura [1 ]
Dentone, Chiara [1 ]
Battaglini, Denise [3 ,5 ]
Robba, Chiara [3 ,4 ]
Pelosi, Paolo [3 ,4 ]
Bassetti, Matteo [1 ,2 ]
机构：
[1] San Martino Policlin Hosp, Infect Dis Unit, IRCCS Oncol & Neurosc, I-16132 Genoa, Italy
[2] Univ Genoa, Dept Hlth Sci DISSAL, I-16132 Genoa, Italy
[3] San Martino Policlin Hosp, Anesthesia & Intens Care, IRCCS Oncol & Neurosci, I-16132 Genoa, Italy
[4] Univ Genoa, Dept Surg Sci & Integrated Diagnost DISC, I-16132 Genoa, Italy
[5] Univ Barcelona, Dept Med, Barcelona 08007, Spain
来源：
FRONTIERS IN BIOSCIENCE-LANDMARK | 2021年 / 26卷 / 09期
关键词：
D O I：
10.52586/4954
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：405 / 408
页数：4
相关论文
共 50 条
  • [1] Immunomodulatory and anti-inflammatory potential of crocin in COVID-19 treatment
    Ghasemnejad-Berenji, Morteza
    JOURNAL OF FOOD BIOCHEMISTRY, 2021, 45 (05)
  • [2] Anti-inflammatory drugs in COVID-19
    Elnady, Mohamed
    EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2021, 70 (05): : 16 - 18
  • [3] Obesity, inflammatory and thrombotic markers, and major clinical outcomes in critically ill patients with COVID-19 in the US
    Friedman, Allon N.
    Guirguis, John
    Kapoor, Rajat
    Gupta, Shruti
    Leaf, David E.
    Timsina, Lava R.
    OBESITY, 2021, 29 (10) : 1719 - 1730
  • [4] Relationship between blood gases and inflammatory markers with clinical outcomes in critically ill patients with COVID-19
    Morais, N.
    Leonez, L. Candice Costa De Morais
    De Almeida, V. Duarte
    De Andrade, M. Fernandes
    Cosme Do Nascimento, E. Gurgel
    Fernandes, J. Verissimo
    Bezerra, C. Medeiros
    Araujo De Medeiros Fernandes, T. Allyrio
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [5] Tocilizumab exerts anti-inflammatory activity in six critically ill COVID-19 patients: a retrospective analysis
    Qian, Shen
    An, Jianghong
    Qi, Furong
    Ye, Ling
    Chen, Qiong
    Liu, Xunqi
    Xie, Lixin
    Li, Guobao
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (14)
  • [6] Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19
    Zhang, Jing
    Sheng, Hongguang
    Tang, Xiaoyi
    Xia, Panpan
    Li, Zhangwang
    Xu, Minxuan
    Ma, Jianyong
    Shen, Yunfeng
    Yu, Peng
    Liu, Xiao
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [7] The use of nonsteroidal anti-inflammatory drugs by COVID-19 patients - in a nutshell
    Flepisi, B. T.
    Schellack, N.
    SA PHARMACEUTICAL JOURNAL, 2021, 88 (03) : 35 - 38
  • [8] Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
    Micallef, Joelle
    Soeiro, Thomas
    Jonville-Bera, Annie-Pierre
    THERAPIE, 2020, 75 (04): : 355 - 362
  • [9] Use of Nonsteroidal Anti-inflammatory Drugs for COVID-19 Infection: Adjunct Therapy?
    Zhao, Daniel
    Zhang, Sandy
    Igawa, Teryn
    Frishman, William
    CARDIOLOGY IN REVIEW, 2020, 28 (06) : 303 - 307
  • [10] Does use of nonsteroidal anti-inflammatory drugs increase patients' clinical severity of COVID-19?
    Barros de Oliveira, Henrique Souza
    SAO PAULO MEDICAL JOURNAL, 2021, 139 (04): : 418 - 419
12345